News & Events


Date Title
October 12, 2017
NEW YORK (GenomeWeb) – Stakeholders in the liquid biopsy field gathered yesterday to discuss the state of the science for blood-based cancer genomics, to quantify the challenges facing test developers and regulators, and to discuss ongoing projects and new data.
August 22, 2017
To ensure the accuracy of patient testing results, clinical next-generation sequencing (NGS) labs must track metrics across their assay’s workflow to determine whether runs were within established limits. Without software to help manage this data, labs must manually compile and trend data to determine whether a run passed or failed, introducing the possibility of transcription errors and adding to the turnaround time for patient results.
August 1, 2017
SeraCare Life Sciences, Milford, Mass, has launched Seraseq Circulating Tumor DNA v2 reference materials, aimed to closely mimic the performance attributes of ctDNA derived from clinical specimens.
July 24, 2017
NEW YORK (GenomeWeb) – As liquid biopsy genetic tests have rocketed into clinical practice over the last handful of years, clinical researchers, test developers, and others have begun to pay increasing attention to a relative lack of tools to ensure assays are validated and performed according to common, or at least equivalent standards
Click to see a full listing of News articles